It has been discovered that FRK mostly inhibits tumor cell growth in gliomas and breast cancer (Yim et al., 2009); by contrast, FRK contributes to the development of tumors in cases of pancreatic and hepatocellular carcinoma (Goel and Lukong, 2016). The gene discussed is FRK; the disease is hepatocellular carcinoma.